Skip to main content
OpenTrials
Completed

NCT Number: NCT05038501

Prevalence of Comorbidities in Patients Undergoing Oncosurgeries at Tertiary Cancer Institute in North India.

Investigators plan to study the prevalence of comorbidities in patients undergoing oncosurgeries

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Comorbidities and Coexisting Conditions

Age range

35 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Anita Kulkarni

Delhi, 110085, India

About this study

Plan to study the prevalence of Coronary Artery Disease, Hypertension, Diabetes Mellitus, Hypothyroidism, History of Corona Virus infection in patients undergoing oncosurgeries.

In the Pre anesthesia checkup patients age , sex , Weight in kilograms, Height in centimeters , pulse rate, Blood Pressure will be noted and value>140/90 mmHg will be taken as hypertensive. History will be obtained about diagnosed Coronary Artery Disease , Diabetes Mellitus, Hypertension , Hypothyroidism , History of previous Corona Virus Infection (RT-PCR Test Positive) .Relevant investigations Electrocardiography and Echocardiography for assessment of Coronary Artery Disease. Fasting or Random Blood Sugar , Thyroid Function Test will be done .

Fasting Blood Sugar >126 milligram/ Decilitre and Random Blood sugar >200mg/dL will be taken as diabetic. TSH more than 5 micro IU/mL will be hypothyroid .

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients undergoing Oncosurgeries Age above 40 years .

-

Exclusion criteria

Age below 40 years Emergency Surgery Patient Refusal

Treatment and study plan

To study comorbidities in patients undergoing Oncosurgeries

Other

In the Preoperative Anaesthesia checkup we will study prevalence of comorbidities as Coronary artery Disease, Hypertension, Diabetes Mellitus , Hypothyroidism and prior Corona Virus Infection in patients undergoing Oncosurgeries

Primary outcomes

  1. To study Coronary Artery disease in patients undergoing Oncosurgeries

    Time frame: 60 days

    Electrocardiography and Echocardiography will be performed.

    Investigators will measure Blood Pressure , Blood Sugar , Thyroid Function Test and previous Corona Virus Infection

  2. To study Diabetes Mellitus in patients undergoing Oncosurgeries.

    Time frame: 60days

    Random Blood Sugar in milligram/Decilitre will be measured.

Secondary outcomes

  1. To study Hypothyroidism in patients undergoing Oncosurgeries

    Time frame: 60 days

    Thyroid Stimulating Hormone (TSH) in micro IU / millilitre will be measured.

Sponsors and collaborators

Lead sponsor

Rajiv Gandhi Cancer Institute & Research Center, India

Other

Registry information

Official study title

Prevalence of Comorbidities in Patients Undergoing Oncosurgeries at Tertiary Cancer Institute in North India

Acronym: oncosurgery

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Sep 9, 2021
Registry last updated
Oct 4, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.